Adicet Bio, Inc. (ACET) SEC Filings — 2024

Filings

• Adicet Bio Files 8-K Report — 8-K · Dec 19, 2024
• Adicet Bio Terminates Regeneron Deal — 8-K · Nov 27, 2024
• Adicet Bio Files 8-K Report — 8-K · Nov 18, 2024
• Adicet Bio, Inc. Enters Material Definitive Agreement — 8-K · Nov 15, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• Adicet Bio Files Q3 2024 10-Q, Discloses R&D Expenses — 10-Q · Nov 6, 2024
• Adicet Bio Files 8-K Report — 8-K · Oct 16, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Oct 8, 2024
• Adicet Bio Files 8-K: Financial Statements & Exhibits — 8-K · Sep 30, 2024
• Adicet Bio Files 8-K Report — 8-K · Sep 19, 2024
• Adicet Bio Appoints New Chief Medical Officer — 8-K · Sep 10, 2024
• Adicet Bio Announces Board Changes and Executive Compensation Updates — 8-K · Aug 19, 2024
• Adicet Bio Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Jul 10, 2024
• Adicet Bio Files 8-K Report — 8-K · Jul 8, 2024
• Adicet Bio Files 8-K Report — 8-K · Jun 24, 2024
• Adicet Bio Adds Directors, Amends Bylaws — 8-K · Jun 7, 2024
• Adicet Bio Files 8-K — 8-K · Jun 5, 2024
• Adicet Bio, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
• Adicet Bio Files 8-K for Reg FD and Financials — 8-K · May 10, 2024
• Adicet Bio, Inc. Files DEF 14A with Executive Compensation Details — DEF 14A · Apr 23, 2024
• Adicet Bio Files 8-K Report — 8-K · Apr 22, 2024
• Adicet Bio, Inc. Files 8-K for Material Agreement — 8-K · Mar 22, 2024
• Orbimed Amends Adicet Bio Stake — SC 13D/A · Mar 21, 2024
• Adicet Bio, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
• Adicet Bio, Inc. SC 13G Filing — SC 13G · Feb 27, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Adicet Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Morgan Stanley Discloses Initial Passive Stake in Adicet Bio (ACET) — SC 13G · Feb 12, 2024
• Carlyle Group Amends Adicet Bio Stake, Ownership Update Filed — SC 13D/A · Feb 7, 2024
• BlackRock Amends Adicet Bio Stake, Signals Ownership Change — SC 13G/A · Feb 7, 2024
• RA Capital Discloses 10.3% Stake in Adicet Bio — SC 13G · Feb 5, 2024
• Cowen Financial Products Reports 2.7M Share Stake in Adicet Bio — SC 13G/A · Feb 2, 2024
• BlackRock Amends Adicet Bio Stake, Updates Passive Investment — SC 13G/A · Jan 31, 2024
• OrbiMed Updates Adicet Bio Stake: Institutional Ownership Shift — SC 13D/A · Jan 29, 2024
• Adicet Bio Files 8-K on Material Agreement, Financial Condition — 8-K · Jan 24, 2024
• State Street Corp Amends Adicet Bio Stake as of Dec 31, 2023 — SC 13G/A · Jan 23, 2024
• Commodore Capital Takes 9.9% Stake in Adicet Bio — SC 13G · Jan 19, 2024
• Adicet Bio Files Routine 8-K, Confirms Nasdaq Listing — 8-K · Jan 16, 2024
• Adicet Bio Updates Corporate Address, Phone in 8-K Filing — 8-K · Jan 4, 2024